Early Access

10-KPeriod: FY2017

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2017

Filed February 13, 2018For Securities:UNH

Summary

UnitedHealth Group's 2017 10-K filing reveals a strong financial performance driven by robust growth across its UnitedHealthcare and Optum segments. The company demonstrated significant revenue increases, bolstered by expansion in Medicare Advantage and Medicaid, alongside consistent growth in its health services arm, Optum. Diluted earnings per share saw a substantial jump, partly attributed to the Tax Cuts and Jobs Act, which positively impacted the company's tax rate. Strategically, UnitedHealth Group continues to leverage its dual platform approach, with UnitedHealthcare offering diversified health benefits and Optum providing a suite of health services. The company's commitment to innovation is evident in its increasing engagement with value-based care models and its continuous investment in technology and data analytics. Despite facing pressures in Medicare Advantage funding and the return of the Health Insurance Industry Tax, UnitedHealth Group maintains a positive outlook, focusing on operational efficiency and member-focused care to drive future growth and profitability.

Financial Statements
Beta
Revenue$201.16B
Cost of Revenue$24.11B
Gross Profit$177.05B
SG&A Expenses$29.56B
Operating Expenses$185.95B
Operating Income$15.21B
Interest Expense$1.19B
Net Income$10.56B
EPS (Basic)$10.95
EPS (Diluted)$10.72
Shares Outstanding (Basic)964.00M
Shares Outstanding (Diluted)985.00M

Key Highlights

  • 1Consolidated revenues increased by 9% to $201.16 billion, driven by 10% growth in UnitedHealthcare and 9% growth in Optum.
  • 2Diluted earnings per share (EPS) rose significantly by 48% to $10.72, with $1.22 of this increase attributable to the Tax Cuts and Jobs Act.
  • 3UnitedHealthcare segment experienced strong membership growth, particularly in Medicare Advantage (up 22%) and Medicaid (up 14%).
  • 4Optum segment reported solid revenue and earnings growth across all its sub-segments: OptumHealth, OptumInsight, and OptumRx.
  • 5Cash flows from operations were robust, increasing by 39% to $13.6 billion, indicating strong operational cash generation.
  • 6The company returned significant capital to shareholders through dividends ($2.77 billion) and share repurchases ($1.5 billion) in 2017.

Frequently Asked Questions